Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay. (2021)
Attributed to:
One Health and accelerating Vaccines for Ebola and Lassa (OVEL)
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/tropicalmed6030155
PubMed Identifier: 34449756
Publication URI: http://europepmc.org/abstract/MED/34449756
Type: Journal Article/Review
Volume: 6
Parent Publication: Tropical medicine and infectious disease
Issue: 3
ISSN: 2414-6366